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Background/ aim: Malnutrition is common in patients with nonischemic dilated cardiomyopathy (DCM), especially in the end stages
of the disease where heart failure symptoms predominate. Malnutrition has been associated with atherosclerosis in patients with chronic
kidney disease, but it is unknown whether a similar relationship exists between malnutrition and coronary microvascular dysfunction
(CMD). In the present study, we aimed to analyse whether indices of malnutrition were associated with coronary flow reserve (CFR) in
patients with DCM.
Materials and methods: A total of 33 cases who were prospectively followed up with by institutional DCM registry were found eligible
for inclusion. Coronary flow reserve was measured with transthoracic echocardiography from the left anterior descending artery. The
study sample was divided into 2 groups using a CFR cut-off value of 2.0. Geriatric nutritional index (GNI), prognostic nutritional index
(PNI), and C-reactive protein/albumin ratio (CAR) were calculated.
Results: A total of 17 out of 33 cases (51.5%) had a low (<2.0) CFR. Both GNI and PNI were similar between the 2 groups, but the
inflammatory–nutritional parameter CAR was significantly higher in those with a low CFR (1.18 ± 0.64 vs. 0.54 ± 0.28, P < 0.001). CAR
remained an independent predictor of CFR on multivariate regression (β = 0.65, P < 0.001) after adjustment for demographic (age, sex,
body mass index), nutritional (GNI, PNI, albumin), and inflammatory (C-reactive protein) parameters. For a cut-off value of 0.80, CAR
had a sensitivity of 85.7% and specificity of 73.6% to predict a CFR <2.0 (AUC: 0.835, 95%CI: 0.693–0.976, P = 0.001).
Conclusions: Our findings indicate that not malnutrition per se but a combination of inflammation activation and malnutrition is
predictive of CMD in patients with DCM.
Key words: Transthoracic echocardiography, nonischemic dilated cardiomyopathy, coronary flow reserve, malnutrition, inflammation

1. Introduction
Nonischemic dilated cardiomyopathy (DCM) is the final
consequence of various pathologic processes that cause
myocardial damage and is a common cause of heart
failure (HF) syndrome. By definition, DCM excludes
significant epicardial coronary disease or previous
myocardial infarction as the cause of initial myocardial
insult, but a reduced coronary flow reserve (CFR) is
observed in a fraction of DCM patients [1,2]. This
reduction in coronary flow reserve (CFR) is explained
by coronary microvascular dysfunction (CMD), which
is secondary to structural alterations, elevated left
ventricular end-diastolic pressure externally compressing
intramyocardial arterioles and capillaries, and endothelial
dysfunction (ED) due to reduced bioavailability of nitric
oxide and formation of free radicals [3]. Reduced CFR
is associated with worsening left ventricular function,

disease progression, and an overall worse prognosis in
DCM patients [4].
Patients with HF syndrome, including those with DCM,
are in an inflammatory–catabolic state, which can manifest
itself as cardiac wasting at the latter stages of the disease
where HF syndrome predominates [5,6]. Malnutrition is
a common finding, seen in up to 50% of patients with HF,
and is related with increased morbidity and mortality [7].
Given the strong association between dietary patterns and
micronutrients with endothelial function, it is plausible to
consider malnutrition as a possible mechanism aggravating
CMD [8]. In our experience, CMD is related to abnormal
liver enzymes and metabolism end-products such as uric
acid in DCM patients, suggesting that abnormalities in
metabolism are linked to abnormal microvascular function
[9,10]. Data in patients with chronic kidney disease (CKD)
undergoing dialysis suggest such an association, which is
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termed malnutrition, inflammation, and atherosclerosis
(MIA) syndrome [11,12]. The effects of inflammation and
malnutrition in other patients, such as those with DCM,
as well as the impact on microvascular function, are
practically unknown due to a lack of relevant data.
In the present study, we aimed to study the relationship
between CFR and nutritional indices, including geriatric
nutritional index (GNI), prognostic nutritional index
(PNI), inflammatory–nutritional index, and C-reactive
protein (CRP) to albumin ratio (CAR) in a pilot study in
order to understand the effects of nutrition on CMD and
to investigate whether these indices could be useful for
predicting CFR in patients with DCM.
2. Materials and methods
For the present study, we used data from an institutional
registry that prospectively follows up with patients with
DCM. Patients that were older than 18 years old and
had at least 2 echocardiographic examinations that were
done 6 months apart and showed a left ventricular (LV)
ejection fraction of ≤50% and evidence for LV dilation
(LV end-diastolic volume greater than 2 SD from an upper
reference limit corrected for age and sex) were screened
for inclusion to the present work. All patients included
in the present study underwent coronary angiography
as part of their initial DCM work-up, and patients with
any evidence of atherosclerotic coronary artery disease
on this angiography or a history of myocardial infarction
were excluded regardless of the significance of underlying
coronary artery disease. Other exclusion criteria included
the following: cardiac conditions with known effects on
CFR, such as other types of cardiomyopathies; a medical
history of systemic diseases with known effects on
microvascular function, such as diabetes, hypertension,
thyroid diseases, or systemic rheumatologic disorders;
other organ failures that may affect CFR, such as stage 3
or more advanced chronic kidney disease or moderate to
severe liver impairment; and those with conditions that
may affect measurement of CFR, such as persistent atrial
arrhythmias or very frequent extrasystoles. Finally, patients
that were smokers and those with a history of substance
abuse (including alcohol) were also excluded given the
close relationship between these habits and CFR. A total
of 33 cases were found eligible based on these criteria
and were subsequently enrolled. All patients included
to the present study had New York Heart Association
(NYHA) class 2–3 HF and received guideline-directed
medical treatment at the maximum doses tolerated.
Demographic, anthropometric, clinical, laboratory, and
echocardiographic data were collected from registry data
using paper charts or electronic databases.
The present study was conducted according to the
principles of the 1975 Declaration of Helsinki. An ethics

approval was obtained from a local ethics committee
before starting the study. All patients gave their written
consent before inclusion to the registry, but no additional
consent was sought for the present study.
2.1. Echocardiographic assessment of coronary flow
reserve
Detailed methodology for the echocardiographic
measurement of CFR has been presented before [13]. In
brief, all measurements were done from the left anterior
descending artery (LAD) by visualizing the LAD from a
modified 2- or 4-chamber view while the patient was in the
left lateral position. Coronary blood flow velocities were
measured using pulsed wave Doppler at rest immediately
after dipyridamole infusion (0.56 mg/kg over 4 min).
The 5 highest diastolic velocities recorded during the test
were averaged to obtain the diastolic peak flow velocities
(DPFV) at baseline, during maximal dipyridamole
infusion, and 3 min after cessation of dipyridamole. All
echocardiographic examinations were performed by
an investigator experienced in echocardiography and
echocardiographic assessment of CFR (Dr. MC) using an
ultrasound platform (Philips EPIQ 7G, Bothell, WA, USA)
equipped with a broadband S5-1 transducer (transmission
frequency: 1.7 MHz; receiver frequency: 3.4 MHz). CFR
was defined as the ratio of hyperemic diastolic peak
velocity to baseline diastolic peak velocity, and a CFR ≥
2.0 was considered normal.
2.2. Calculation of nutritional indices
Geriatric nutritional index was calculated using serum
albumin, height, and body weight using the following
formula [14]: GNI = [14.89 × albumin (g/dL)] + [41.7 ×
(body weight / ideal body weight)]; where ideal body mass
index (BMI) was assumed as 22 kg/m2 and ideal body
weight was calculated using ideal BMI and actual height.
Prognostic nutritional index was calculated using
serum albumin and absolute lymphocyte count in the
peripheral blood using the following formula [15]: 10 ×
serum albumin value (g/dL) + 0.005 × absolute lymphocyte
count (/mm3).
The inflammatory–nutritional parameter CAR was
calculated by simply dividing CRP (mg/dL) by serum
albumin [16].
3. Statistical analyses
All statistical analyses were performed using JASP (JASP
Team, 2019; Version 0.10.2 for Windows) and SPSS
17.0 (IBM Inc., Armonk, NY, USA) statistical software.
Patients were divided into 2 subgroups according to CFR.
Continuous variables were given as mean ± SD, while
categorical variables were presented as percentages. For
continuous variables, Shapiro–Wilk and Levene’s tests
were used to analyse distribution patterns and equality
of variances in these subgroups, respectively. Student’s
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t-test, with Welch correction if the variances were not
equal, was used for variables with a normal distribution.
For parameters without a normal distribution pattern, the
Mann–Whitney U test was used. Correlation analyses were
done with the Pearson test for parameters with a normal
distribution, and Spearman’s rho was used for parameters
with a severely skewed distribution. For categorical
variables, ki2 or Fisher’s exact tests were used depending
on expected cell counts. Receiver–operator characteristic
(ROC) curves were drawn to determine accuracy and
optimal cut-off for variables that had the highest likelihood
for predicting a CFR < 2.0. For nutritional parameters that
offered the highest accuracy for predicting CFR, cut-off
values were determined using ROC curves; these cut-off
values were used to convert scalar nutritional indices into
binomial parameters. A multivariate logistic regression
model with forward likelihood selection criteria was built
to adjust the effects of confounders on the tested variables.
Categorical variables were introduced to the multivariate
liner regression model using dummy parameter coding.
This model was bootstrapped 5000 times to improve overall
model accuracy. Finally, a logistic regression model was
built using binomial parameters to study whether cut-off
values found on ROC curves offered adequate predictive
capability to determine a low (<2.0) CFR in DCM patients.
A P value of <0.05 was accepted as the limit for statistical
significance.
4. Results
Mean age of the study population was 55.64 ± 11.24 and
23 (69.7%) of the patients were male, with a mean BMI of
27.62 ± 4.38 kg/m2. Mean ejection fraction and CFR were
0.37 ± 0.09 and 2.05 ± 0.39, respectively, for the whole
study group. Sixteen patients had a CFR ≥ 2.0 (48.5%),
while the remaining 17 patients (51.5%) had a CFR < 2.0.
Mean hemoglobin, glucose, total cholesterol, triglycerides,
and albumin levels were 14.18 ± 0.96 g/dL, 99.03 ± 8.64
mg/dL, 172.55 ± 36.92 mg/dL, 141.58 ± 57.87 mg/dL, and
3.95 ± 0.45 g/dL, respectively. Mean GNI and PNI were
111.41 ± 12.32 and 49.15 ± 6.87 in the study population,
while median CAR was 0.87 ± 0.59.
4.1. Coronary flow reserve subgroups
Demographic, clinical, laboratory, and echocardiographic
data for patients with CFR <2.0 and ≥2.0 are summarized
in Table 1. There were no significant differences between
groups for age, sex, or BMI, but there was a trend toward
higher systolic and diastolic blood pressure in those
with a low CFR. On echocardiography, left ventricular
ejection fraction was lower (P = 0.06) and left ventricular
filling pressure was significantly higher (P = 0.001) in
the subgroup of patients with CFR <2.0. Albumin, total
cholesterol, and triglyceride levels were all lower in
those with a CFR < 2.0, although none were statistically
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significant. In contrast, CRP was significantly higher in
patients with a CFR <2.0. For nutritional variables, only
CAR showed a significant elevation in the subgroup of
patients with a CFR <2.0, while no statistically significant
differences were observed for other parameters (Table 1).
4.2. Diagnostic accuracy and optimal cut-off value for
C-reactive protein/albumin ratio to determine coronary
flow reserve
When all nutritional parameters were analysed for their
accuracy to determine CFR in DCM patients, only CAR
was found to have a statistically significant area under
curve (AUC) to determine a CFR of less than 2.0 (AUC:
0.835, 95% CI: 0.693–0.976, P = 0.001). In contrast, both
GNI (AUC: 0.522, P = 0.83) and PNI (AUC: 0.548, P =
0.64) did not have a statistically significant association
with CFR (Figure 1). For a cut-off value of 0.80, CAR
had a sensitivity of 85.7%, specificity of 73.6%, a positive
predictive value of 70.5%, and a negative predictive value
of 87.5%.
4.3. Adjustment for confounding factors
On univariate analysis, CAR had a moderate to strong
correlation with CFR with a correlation coefficient of
–0.73 (P <0.001). A multivariate model was used to adjust
that association between CAR and CFR for demographic
and anthropometric variables (age, sex, and BMI) and
other nutritional indices (GNI and PNI). Additionally, this
model was adjusted for CRP and albumin to understand
whether CAR would have a predictive value independent
of its constituent variables. CAR remained as the only
independent parameter that was associated with CFR
following multivariate adjustment; this finding remained
the same after bootstrapping the model (Table 2). A
similar finding was obtained when CAR was included in
the logistic regression model with the same covariates,
where CAR was the sole parameter that determined a CFR
<2.0 with an odds ratio of 14.30 (95% CI: 2.30–88.8, P =
0.004).
4.4. Correlation of C-reactive protein/albumin ratio with
other echocardiographic variables
C-reactive protein/albumin ratio had statistically significant
correlations with left ventricular end-diastolic volume (r
= 0.51, P = <0.001) and LV systolic volume (r = 0.46, P
= 0.01). In contrast, no such associations were observed
between CAR and left ventricular ejection fraction (r =
–0.17, P = 0.36) or between CAR and mean E/e’ ratio (r
= 0.08, P = 0.66), the latter being an echocardiographic
marker of left ventricular filling pressure (Figure 2).
5. Discussion
In the present study, we sought to understand the
relationship between nutritional indices and CFR in
patients with nonischemic DCM. Key takeaways from the

KUL et al. / Turk J Med Sci
Table 1. Demographic, clinical, laboratory, and echocardiographic characteristics of dilated cardiomyopathy patients
grouped according to coronary flow reserve (CFR). Note that patients with a low CFR had similar geriatric and prognostic
nutritional indices as compared to those with a normal CFR, but CRP to albumin ratio was significantly higher in the
former group. Comparisons with a P value below 0.05 were written in bold. CFR, coronary flow reserve; DCM, dilated
cardiomyopathy; BP, blood pressure; CRP, C-reactive protein; LV, left ventricle; BMI, body mass index.
DCM patients with CFR
≥ 2.0

DCM patients with CFR
< 2.0

P

Age (years)

56.1 ± 9.7

55.2 ± 12.9

0.81

Sex (male%)

12 (75.0%)

11 (64.7%)

0.71

Height (cm)

168.7 ± 9.1

165.5 ± 9.9

0.35

Weight (kg)

76.8 ± 14.1

78.3 ± 17.1

0.79

BMI (kg/m )

27.22 ± 3.81

27.99 ± 4.97

0.63

Systolic BP (mmHg)

116.4 ± 8.1

124.7 ± 14.9

0.06

Diastolic BP (mmHg)

74.3 ± 4.5

79.2 ± 8.0

0.07

Heart rate (beats/min)

73.1 ± 9.8

71.0 ± 15.0

0.65

White blood cell count (x103)

8.03 ± 2.28

8.62 ± 1.68

0.40

Hemoglobin (g/dL)

14.24 ± 0.94

14.12 ± 1.00

0.97

Lymphocyte count (×10 )

1.87 ± 0.89

1.97 ± 1.03

0.66

CRP (mg/dL)

2.17 ± 1.00

4.52 ± 2.42

0.001

Blood glucose (mg/dL)

99.93 ± 9.40

98.25 ± 8.15

0.60

Blood urea nitrogen (mg/dL)

14.60 ± 2.97

19.25 ± 8.82

0.27

Creatinine (mg/dL)

0.97 ± 0.24

1.12 ± 0.32

0.20

Albumin (g/dL)

4.04 ± 0.48

3.86 ± 0.42

0.26

Total cholesterol (mg/dL)

177.81 ± 39.69

167.59 ± 34.56

0.44

Triglycerides (mg/dL)

146.19 ± 60.51

137.24 ± 56.77

0.66

Sodium (meq/L)

140.38 ± 1.89

139.60 ± 2.26

0.33

LV end-diastolic volume (mL)

178.20 ± 47.92

219.35 ± 74.86

0.10

LV end-systolic volume (mL)

110.53 ± 47.37

146.76 ± 52.54

0.04

LV ejection fraction (%)

39.71 ± 9.71

33.59 ± 7.67

0.06

Mean E/e’ ratio

6.53 ± 2.05

13.52 ± 8.47

0.001

Geriatric nutritional index

111.26 ± 11.17

111.55 ± 13.66

0.95

Prognostic nutritional index

49.81 ± 7.16

48.52 ± 6.74

0.66

CRP: albumin ratio

0.54 ± 0.28

1.18 ± 0.64

<0.001

Basal flow velocity (m/s)

25.44 ± 5.46

29.12 ± 8.81

0.25

Hyperaemic flow velocity (m/s)

59.88 ± 14.76

51.00 ± 14.20

0.10

Coronary flow reserve

2.36 ± 0.31

1.76 ± 0.15

<0.001

Parameter
Demographic and anthropometric variables

2

Clinical variables

Laboratory variables

3

Echocardiographic variables

Nutritional indices

Flow indices
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Figure 1. Receiver-operator characteristic (ROC) curves showing accuracy of
nutritional indices to predict a coronary flow reserve <2.0 in patients with nonischemic
dilated cardiomyopathy. Of all indices studied, only C-reactive protein to albumin
ratio (blue line) had a statistically significant c-statistic (AUC 0.835, P = 0.001) to
predict a low coronary flow reserve. See text for details. CRP, C-reactive protein.
Table 2. Univariate and multivariate predictors of coronary flow reserve
in patients with dilated cardiomyopathy. Note that parameters other than
C-reactive protein to albumin ratio were included to the model for adjustment.
The results remained valid after bootstrapping the model for 5000 iterations.
CRP, C-reactive protein; BMI, body mass index; GNI, Geriatric nutritional
index; PNI, prognostic nutritional index.
Univariate correlation

Multivariate regression

r

P

β

P

CRP: albumin ratio

–0.73

<0.001

–0.65

<0.001

CRP (adjustment)

–0.70

<0.001

Albumin (adjustment)

0.18

0.32

Age (adjustment)

0.09

0.63

Sex (adjustment)

–0.01

0.97

BMI (adjustment)

–0.01

0.98

GNI (adjustment)

0.03

0.89

PNI (adjustment)

0.19

0.29

Parameter

present study are as follows: i) Of all nutritional indices
studied, only the inflammatory–nutritional index CAR
has shown an association with CFR, while sole nutritional
indices such as GNI or PNI did not have such a relationship
with CFR; ii) This association between CAR and CFR was
independent of confounders, including parameters that
constituted CAR, namely CRP and albumin; iii) Using a
cut-off value of 0.80, CAR offers an accuracy of 78.8% for
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correct estimation of a CFR <2.0; and iv) CAR showed a
significant correlation with LV dimensions, but not with
LV ejection fraction or filling pressure.
5.1. Inflammation, malnutrition, and coronary flow reserve
in patients with nonischemic dilated cardiomyopathy
Coronary microvascular flow is affected by several factors,
including endothelial function, metabolic factors, capillary
density in myocardium, and external compression [3]. By
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Figure 2. Scatter plots showing correlation between C-reactive protein to albumin ratio
with various echocardiographic measurements. C-reactive protein to albumin ratio had
statistically significant correlations with left ventricular end-diastolic pressure and endsystolic pressure (panels A and B), but not with left ventricular ejection fraction or mean E/e’
ratio (panels C and D), the latter being an echocardiographic surrogate for left ventricular
filling pressure. See text for details. CRP, C-reactive protein.

affecting NO metabolism and bioavailability in vascular
endothelium, inflammation has well-known effects on
endothelial function; both acute and chronic inflammation
lead to ED and hence CMD. Endothelial and coronary
microvascular functions are also affected by dietary
patterns, where unhealthy dietary habits were associated
with ED and vascular aging [8]. Micronutrients such as
dietary electrolytes (potassium, sodium, magnesium)
exert a powerful modifier effect on vascular function;
consumption of specific foods (whey protein, legumes,
olive oil, whole grains, and similar “healthy” foods)
improves endothelial and vascular function by reducing
oxidative stress and inflammation [17–21]. Malnutrition is
frequently observed with inflammation and atherosclerosis
as a triad in patients with chronic kidney disease who
undergo peritoneal dialysis or hemodialysis, thus
suggesting a possible causal role for malnutrition in the
development and progression of atherosclerosis [11,12].
While there is no solid evidence linking malnutrition
with CMD, such an association is likely, given that ED

and CMD are precursor events for the development of
atherosclerotic lesions [22]. A similar mechanism could
be operational in DCM, where absorption and utilization
of nutrients are impaired and the overall metabolism shifts
to a catabolic state, thus leading to malnutrition.
Despite these theoretical considerations, the present
findings do not support an independent association
between indices of nutrition (GNI and PNI) and
CFR. Both indices are well-established markers of
inflammation that are predictors of mortality in patients
with HF in various clinical settings and, as such, the most
straightforward explanation of this finding is a true lack of
association between nutrition and CFR in DCM [23,24].
That said, mean GNI and PNI in the study group (111.4
and 49.2), as well as in those with a low CFR (111.6 and
48.8), were well above the cut-offs found in studies that
were used to predict a poor prognosis (92–98 for GNI and
44.8 for PNI) [23,24]. As malnutrition was not severe in
the study population, it remains uncertain whether severe
malnutrition and cardiac cachexia could affect CFR in
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some DCM patients. For the remaining majority of DCM
patients in whom malnutrition is either nonexistent or
less than severe, it can be presumed that nutritional status
per se does not have a major effect on CMD, based on the
present findings.
In contrast to other nutritional indices, CAR was
associated with CFR; this finding remained valid after
adjusting for CRP and albumin, and patients with a CAR
> 0.8 were approximately 13 times more likely to have a
CFR < 2.0. This finding could imply that coexistence
of inflammation and malnutrition induces coronary
microvascular dysfunction in DCM patients, similar to
malnutrition, inflammation, and atherosclerosis (MIA)
syndrome seen in patients with CKD [11]. As mentioned
before, other indices of malnutrition do not suggest that
malnutrition was prevalent in the subset of patients with
a low CFR, thus calling for other potential explanations.
Since albumin is a negative acute-phase reactant, the
patients with high CAR may simply represent a subset of
patients with more pronounced inflammatory activation.
In a previous study, patients with DCM and a CFR <
2.0 had higher serum CRP, tumor necrosis factor-α, and
interleukin-1 levels compared to those with a CFR ≥ 2.0,
thus supporting this latter explanation [25]. That said,
our findings do not support a linear relationship between
albumin and CRP (data not shown), thus suggesting that
the relationship is either nonlinear or that other factors
besides inflammation have a significant impact on serum
albumin level in the study cohort. Finally, a low CFR in
the setting of inflammation and hypoalbuminemia may
imply widespread endothelial dysfunction involving
both coronary and renal microvasculature, where
hypoalbuminemia is a manifestation of renal dysfunction
rather than malnutrition. In patients with systemic
hypertension and normal coronary arteries, Tsiachris et al.
have demonstrated that CFR was correlated with urinary
albumin excretion, thus implying a generalized vascular
disease that involves both coronary and renal vasculature
in this patient group (26). While there is no direct evidence
to support that a similar mechanism is operational in
DCM, such a mechanism is plausible given that CMD
frequently involves both organs, and albuminuria with or
without manifest renal dysfunction is seen in up to 30%
of patients with renal failure. Unfortunately, data from the
present study are insufficient to prove or refute any of these
possible explanations.
5.2. Possible clinical implications
Regardless of the underlying mechanism, the present
findings showed that high CAR is associated with a low
CFR, a condition that is linked to a worse prognosis in DCM
patients [4]. While there are no data to suggest that CAR
itself is associated with a poor prognosis, this relationship
with CFR, as well as the prognostic implications of
inflammation and hypoalbuminemia in patients with HF,
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could be considered as indirect evidence linking CAR with
overall prognosis. Our findings also indicate that CAR
has a high diagnostic accuracy in determining a CFR <
2.0; as such, a high CAR could be considered a surrogate
marker for microvascular dysfunction in patients with
DCM. Microvascular dysfunction is a potential target
for HF, but measuring CFR or other surrogate markers of
microvascular dysfunction in everyday practice remains
challenging as complex or invasive methods are needed
to determine microvascular dysfunction [27,28]. As such,
CAR could be useful for screening patients with DCM and
possible microvascular dysfunction to select patients for
more definitive testing. Finally, several ongoing studies
are aimed at correcting individual components of CAR—
namely inflammation and hypoalbuminemia—to see
whether such strategies can correct endothelial function
(25). CAR could be a useful tool to monitor responses to
such therapies; it could be expected that a decline in CAR
would be indicative of better microvascular or endothelial
dysfunction. Since the present study is not oriented
towards possible clinical applications of CAR, assertions
provided in this section should be considered hypothetical
until more solid evidence is available.
As the present findings imply that microvascular
dysfunction is related with both nutrition and
inflammation, it would be reasonable to expect that
strategies or treatments aimed to improve nutrition or
mitigate inflammation could attenuate microvascular
dysfunction. Drugs affecting the renin–angiotensin–
aldosterone axis, such as ACE inhibitors, angiotensin
receptor blockers, or mineralocorticoid receptor blockers,
are used as the primary means of treatment in patients
with heart failure and reduced ejection fraction, including
those with DCM. While these drugs modify a multitude
of pathways, some of their beneficial effects are exerted
via blocking the proinflammatory effects of angiotensin
and aldosterone [29,30]. As such, these drugs may also
improve microvascular function in DCM patients and
perhaps exert some of their beneficial effects via this
mechanism. Indeed, evidence is available to suggest
that renin–angiotensin–aldosterone system blockers
improve coronary microvascular function in patients
with hypertension or Syndrome X, though such evidence
is lacking for DCM [31,32]. Finally, a recently published
CANTOS study found that canakinumab, an interleukin1B inhibitor that is used for the treatment of rheumatoid
arthritis, can reduce hospitalizations for heart failure and
that some of its effects can be mediated via improvement
of microvascular function, but more data is required to
make more definitive comments on this subject [33].
6. Study limitations
The study was done using data from a single center,
the sample size was small, and the data was collected
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retrospectively, all limiting the quality of data used to
obtain results. All findings should be interpreted in this
context. That said, the data was acquired from a prospective
institutional registry with an objective to study coronary
flow dynamics in patients with various conditions and
therefore a standard approach was used to collect data, thus
mitigating the effects of the latter limitation on data quality.
The results were only valid for those with nonischemic
DCM and should not be generalized to all patients with
HF. In each standard approach, CFR was measured only
from the left anterior descending artery and therefore
only represents microvascular function in a limited left
ventricular territory. Nonetheless, the effects of processes
that lead to nonischemic DCM are global and it can be
assumed that the results could be extrapolated to other LV
territories. Finally, adjustments were done for a limited
number of variables due to sample size and lack of data
on all variables; therefore, other factors that might act as

confounders were omitted. These factors should be taken
into consideration when interpreting the present findings.
7. Conclusion
In patients with nonischemic DCM, not malnutrition
per se but the coexistence of inflammation and
hypoalbuminemia, manifested as an elevated CAR, is
associated with coronary microvascular function. This
association remained valid after adjusting for potential
confounders. Further work is required to externally
validate CAR as a surrogate marker of CFR in DCM
patients and to assess whether these findings are also valid
for other patient groups, such as those with ischemic DCM
or HF with preserved ejection fraction.
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